|
regionalization
|
GO:0003002 |
337 |
0.215
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.158
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.155
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.132
|
|
|
renal system development
|
GO:0072001 |
225 |
0.131
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.123
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.120
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.119
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.116
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.115
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.111
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.110
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.107
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.106
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.105
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.103
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.101
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.100
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.099
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.098
|
|
|
lung development
|
GO:0030324 |
164 |
0.098
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.098
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.096
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.092
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.091
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.090
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.089
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.089
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.087
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.086
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.085
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.083
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.082
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.080
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.079
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.079
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.078
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.078
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.078
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.078
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.077
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.076
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.076
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.076
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.076
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.075
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.074
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.074
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.073
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.073
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.073
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.072
|
|
|
kidney development
|
GO:0001822 |
213 |
0.072
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.071
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.069
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.067
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.066
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.066
|
|
|
tube closure
|
GO:0060606 |
91 |
0.065
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.065
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.065
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.065
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.064
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.064
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.063
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.063
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.063
|
|
|
tube formation
|
GO:0035148 |
140 |
0.062
|
|
|
ossification
|
GO:0001503 |
216 |
0.062
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.061
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.060
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.059
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.059
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.059
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.059
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.059
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.059
|
|
|
appendage development
|
GO:0048736 |
166 |
0.059
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.058
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.058
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.058
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.058
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.057
|
|
|
limb development
|
GO:0060173 |
166 |
0.056
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.055
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.055
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.055
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.055
|
|
|
ear development
|
GO:0043583 |
200 |
0.055
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.054
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.054
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.053
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.053
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.053
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.053
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.052
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.052
|
|
|
nephron development
|
GO:0072006 |
109 |
0.051
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.051
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.051
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.051
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.051
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.050
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.050
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.050
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.050
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.050
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.049
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.049
|
|
|
positive regulation of cardiac muscle tissue development
|
GO:0055025 |
19 |
0.049
|
|
|
organ growth
|
GO:0035265 |
117 |
0.049
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.049
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.048
|
|
|
placenta development
|
GO:0001890 |
140 |
0.048
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.048
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.048
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.048
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.048
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.047
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.047
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.047
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.047
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.046
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.046
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.046
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.046
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.046
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.046
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.046
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.046
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.045
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.045
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.045
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.045
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.044
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.044
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.044
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.043
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.043
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.043
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.043
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.043
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.043
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.042
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.042
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.042
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.042
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.042
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.041
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.041
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.041
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.041
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.041
|
|
|
gland development
|
GO:0048732 |
330 |
0.041
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.041
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.040
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.040
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.040
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.040
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.040
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.040
|
|
|
artery development
|
GO:0060840 |
53 |
0.040
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.040
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.039
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.039
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.039
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.039
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.039
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.039
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.039
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.039
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.039
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.039
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.038
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.038
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.038
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.038
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.038
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
15 |
0.038
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.038
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.037
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.037
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.037
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.037
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.037
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.037
|
|
|
pallium development
|
GO:0021543 |
120 |
0.037
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.037
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.037
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.037
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.037
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.037
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.037
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.036
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.036
|
|
|
heart growth
|
GO:0060419 |
45 |
0.036
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.036
|
|
|
foregut morphogenesis
|
GO:0007440 |
12 |
0.035
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.035
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.035
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.035
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.035
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.035
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.035
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.035
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.035
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.035
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.035
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.034
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.034
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.034
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.034
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.034
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.034
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.034
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.034
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.034
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.034
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.034
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.034
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.034
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.034
|
|
|
regulation of cardiac chamber formation
|
GO:1901210 |
1 |
0.034
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.034
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.033
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.033
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.033
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.033
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.033
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.033
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.033
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.033
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.033
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.033
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.033
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.033
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.033
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.033
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.033
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.033
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.032
|
|
|
tongue development
|
GO:0043586 |
18 |
0.032
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.032
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.032
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.032
|
|
|
midgut development
|
GO:0007494 |
4 |
0.032
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.032
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.032
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.032
|
|
|
pulmonary valve formation
|
GO:0003193 |
1 |
0.032
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.032
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.032
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.032
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.031
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.031
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.031
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.031
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.031
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.031
|
|
|
negative regulation of cardiac chamber formation
|
GO:1901211 |
1 |
0.031
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.031
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.031
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.031
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.031
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.031
|
|
|
fertilization
|
GO:0009566 |
127 |
0.031
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.031
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.030
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.030
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.030
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.030
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.030
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.030
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.030
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.030
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.030
|
|
|
positive regulation of heart growth
|
GO:0060421 |
18 |
0.030
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.030
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.029
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.029
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.029
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.029
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.029
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.029
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.029
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.029
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.029
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.029
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.028
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.028
|
|
|
smad protein complex assembly
|
GO:0007183 |
1 |
0.028
|
|
|
negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060829 |
1 |
0.028
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.028
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.028
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.028
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.028
|
|
|
segmentation
|
GO:0035282 |
93 |
0.028
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.028
|
|
|
gonad development
|
GO:0008406 |
141 |
0.028
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.028
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.028
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.028
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.028
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.028
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.028
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.028
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.028
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.028
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.028
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.028
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.027
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.027
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.027
|
|
|
tongue muscle cell differentiation
|
GO:0035981 |
2 |
0.027
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.027
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.027
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.027
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.027
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.027
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.027
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.027
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.027
|
|
|
nephron tubule formation
|
GO:0072079 |
20 |
0.027
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.027
|
|
|
commitment of neuronal cell to specific neuron type in forebrain
|
GO:0021902 |
7 |
0.027
|
|
|
epithelial cell differentiation involved in mammary gland alveolus development
|
GO:0061030 |
4 |
0.027
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.027
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.027
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.027
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.027
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.027
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.027
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.026
|
|
|
middle ear morphogenesis
|
GO:0042474 |
23 |
0.026
|
|
|
regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060827 |
1 |
0.026
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.026
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.026
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.026
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.026
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.026
|
|
|
sinoatrial node development
|
GO:0003163 |
4 |
0.026
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.026
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.026
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.026
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.026
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.026
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.026
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.026
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.026
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.026
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.026
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.026
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.026
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.026
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.026
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.025
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.025
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.025
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.025
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.025
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.025
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.025
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.025
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.025
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.025
|
|
|
recognition of apoptotic cell
|
GO:0043654 |
3 |
0.025
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.025
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.025
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.025
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.025
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.025
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.025
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.025
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.025
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.025
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.025
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.024
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.024
|
|
|
negative regulation of heart looping
|
GO:1901208 |
1 |
0.024
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.024
|
|
|
canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060823 |
1 |
0.024
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.024
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.024
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.024
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.024
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.024
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.024
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.024
|
|
|
heart formation
|
GO:0060914 |
16 |
0.024
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.024
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.024
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.024
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.024
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.024
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.024
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.024
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.023
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.023
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.023
|
|
|
histone modification
|
GO:0016570 |
159 |
0.023
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.023
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.023
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.023
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.023
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.023
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.023
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.023
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.023
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.023
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.023
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.023
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.023
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.023
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.023
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.023
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.022
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.022
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.022
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.022
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.022
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.022
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.022
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.022
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.022
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.022
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.022
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.022
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.022
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.022
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.022
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.022
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.022
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.022
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.022
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.022
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.022
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.022
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.022
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.022
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.022
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.022
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.022
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.022
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.022
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.021
|
|
|
atrioventricular bundle cell differentiation
|
GO:0003167 |
1 |
0.021
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.021
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.021
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.021
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
positive regulation of tongue muscle cell differentiation
|
GO:2001037 |
2 |
0.021
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.021
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.021
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.021
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.021
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.021
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.021
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.021
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.021
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.021
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.021
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.021
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.021
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.021
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.021
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.021
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.021
|
|
|
thymus development
|
GO:0048538 |
41 |
0.021
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.021
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.021
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.021
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.020
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.020
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.020
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.020
|
|
|
bone development
|
GO:0060348 |
120 |
0.020
|
|